Testing effectiveness (Phase 2)Active Not RecruitingNCT06480240What this trial is testingOBI-992 in Subjects With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumor OBI Pharma, Inc 117
Testing effectiveness (Phase 2)Study completedNCT01333540What this trial is testingAssess the Safety, Tolerability and Clinical Activity of TD-1211 in Patients With Opioid-Induced ConstipationWho this might be right forOpioid-induced Constipation (OIC) Glycyx Therapeutics 69
Testing effectiveness (Phase 2)UnknownNCT00453089What this trial is testingVG101 Phase I/II to Treat Vulvar and Vaginal Atrophy in Post-Menopausal WomenWho this might be right forVaginal AtrophyVulvar Atrophy Bionovo 40
Early research (Phase 1)Looking for participantsNCT07371338What this trial is testingPhase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease PatientsWho this might be right forParkinson DiseaseParkinson's Disease Innopeutics Corporation 6
Early research (Phase 1)Study completedNCT01907685What this trial is testingDose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Docetaxel in Patients With Advanced Solid TumorsWho this might be right forAdvanced Neoplastic Disease Sanofi 58
Testing effectiveness (Phase 2)Looking for participantsNCT07761533What this trial is testingPBSS1113 in Combination With Azacitidine to Treat Patients With AML/MDSWho this might be right forAcute Myeloid Leukemia (AML)MDS (Myelodysplastic Syndrome) Chaser Therapeutics, Inc. 29
Early research (Phase 1)Study completedNCT00559975What this trial is testingSafety, Tolerability, Immunogenicity And CPG Dosage Finding Study of Novartis CpG Adjuvanted Flu VaccineWho this might be right forInfluenza Infection Novartis 60
Early research (Phase 1)Ended earlyNCT02170012What this trial is testingA Study In Healthy Elderly People To Evaluate Safety, Toleration, Pharmacokinetics and Pharmacodynamics of Multiple Oral Doses Of PF-06743649Who this might be right forHealthy Elderly Pfizer 24
Early research (Phase 1)Looking for participantsNCT07333430What this trial is testingStudy of Naive HBI0101 CAR-T Therapy in Relapsed/Refractory Multiple MyelomaWho this might be right forRelapsed/Refractory Multiple Myeloma (MM) Hadassah Medical Organization 60
Early research (Phase 1)Ended earlyNCT00595829What this trial is testingXL019 in Adults With Polycythemia VeraWho this might be right forPolycythemia Vera Exelixis 3
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07169175What this trial is testingA Phase Ⅰ/Ⅱa Study of SNUG01 in Adult Subjects With ALSWho this might be right forAmyotrophic Lateral Sclerosis (ALS) SineuGene Therapeutics Co., Ltd. 21
Early research (Phase 1)Study completedNCT00743067What this trial is testingA Dose Escalation Study of the Safety and Pharmacokinetics of GSK1363089 (Formerly XL880) Administered Orally Daily to Subjects With Solid TumorsWho this might be right forSolid Tumours GlaxoSmithKline 37
Very early researchNot Yet RecruitingNCT06888492What this trial is testingTo Evaluate the Safety and Preliminary Efficacy of Intravitreal EXG202 Injection in Patients with Wet (neovascular) Age-related Macular Degeneration (wAMD)Who this might be right forWet Age-related Macular Degeneration (wAMD)Wet Age-related Macular Degeneration Guangzhou Jiayin Biotech Ltd 8
Early research (Phase 1)Not Yet RecruitingNCT06558175What this trial is testingReirradiation Dose Escalation in Thoracic CancersWho this might be right forThoracic CancerLung CancerEsophageal Cancer London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 48
Early research (Phase 1)Study completedNCT00695877What this trial is testingSafety and Immune Response to a Recombinant Adenovirus HIV-1 Vaccine in Healthy AdultsWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 48
Early research (Phase 1)Study completedNCT02647281What this trial is testingFirst Time in Human Study to Assess the Safety, Tolerability and Pharmacokinetics of GSK3389404 in Healthy SubjectsWho this might be right forHepatitis B GlaxoSmithKline 56
Testing effectiveness (Phase 2)Study completedNCT06162728What this trial is testingDose Escalation Trial Of Safety, Pharmacokinetic/Pharmacodynamic And Preliminary Clinical Activity of Briquilimab In Adult Patients With Chronic Spontaneous Urticaria (CSU)Who this might be right forChronic Spontaneous Urticaria Jasper Therapeutics, Inc. 87
Early research (Phase 1)Study completedNCT02171767What this trial is testingSafety and Tolerability of 4 Different Dosage Strengths of BIBW 2992 Tablets to Healthy Male VolunteersWho this might be right forHealthy Boehringer Ingelheim 48
Testing effectiveness (Phase 2)Ended earlyNCT06677307What this trial is testingA Phase 1/2a, Single- and Multiple-dose Escalation Study of KRRO-110Who this might be right forAlpha-1 Anti-trypsin DeficiencyAATD Korro Bio, Inc. 42
Testing effectiveness (Phase 2)Looking for participantsNCT06672536What this trial is testingMulticenter, Phase I/II Study to Evaluate the Safety, Tolerability, PK and Efficacy of SCT520FF in Patients With nAMDWho this might be right fornAMD Sinocelltech Ltd. 82